# LeMaitre Vascular acquires Admedus biologic patch business for up to $24.6M

LeMaitre Vascular has acquired Admedus' CardioCel and VascuCel biologic patch business for up to $24.6 million. Admedus will continue manufacturing for up to three years while LeMaitre sets up its own production.

- Type: Acquisition
- Announced: 2019-10-15
- Where: United States
- Value: $24.6M
- Status: announced
- Products: biologic patches, CardioCel, VascuCel
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [LeMaitre Vascular](https://endata.com/companies/42722.md) (acquirer)
- [Admedus](https://endata.com/companies/42723.md) (target)

## Sources

- [massdevice.com](https://www.massdevice.com/admedus-deals-biologic-patch-business-to-lemaitre-vascular-for-24m/), 2019-10-15: "This transaction is a transformational milestone for Admedus, realizing the value from its CardioCel and VascuCel products."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.